Freenome on Tuesday announced the launch of its new Sanderson Study, which will use its multiomics platform, in combination with real-world data, some derived from Oracle Cerner’s Learning Health Network, to improve detection and treatment of several cancers.
WHY IT MATTERSSan Francisco-based…
Source: Healthcareitnews.com and Read More
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
